Development of biomarker to predict postpoerative delirium and postoperative cognitive decline in cancer patients
Not Applicable
- Conditions
- Postoperative delirium Postoperative cognitive decline
- Registration Number
- JPRN-UMIN000038894
- Lead Sponsor
- ational Cancer Center Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 327
Inclusion Criteria
Not provided
Exclusion Criteria
1. Delirium diagnosis at informed consent 2. Judgement of inappropriateness by the manager or member of research project
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Immunological factor associated with the onset of postoperative delirium and postoperative cognitive decline.
- Secondary Outcome Measures
Name Time Method Metabolomics, epigenome, gene expression, clinical factor, physical remark, electroencephalography associated with the onset of postoperative delirium and postoperative cognitive decline.